Get Live Data

Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Netscientific Share Price
  4. Netscientific Share News
  5. IN BRIEF: NetScientific's portfolio company updates on cancer trial

Pin to quick picksNetscientific Share News (NSCI)

Netscientific Information

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.50
Bid: 67.00
Ask: 68.00
Change: 1.00 (1.50%)
Spread: 1.00 (1.493%)
Open: 66.50
High: 67.50
Low: 66.50
Prev. Close: 66.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: NetScientific's portfolio company updates on cancer trial

Thu, 09th Nov 2023 19:41

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Portfolio company, PDS Biotechnology Corp, announces updated survival data from the Phase 2 clinical trial investigating the triple combination of PDS0101, PDS0301 (IL-12 antibody-drug conjugate) and an investigational immune checkpoint inhibitor in two groups of advanced cancer patients with various types of human papillomavirus 16-positive cancers. Says 75% of immune checkpoint inhibitor naïve patients remain alive at 36 months. In the ICI resistant group, the 12-month OS rate was 72% and the triple combination achieved a median OS of approximately 20 months.

Current stock price: 57.50p

12-month change: down 4%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved

More News
10 Jun 2016 07:41

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

Read more
8 Jun 2016 15:06

UK Shareholder Meetings Calendar - Next 7 Days

Read more
13 Apr 2016 08:39

NetScientfic Highlights Positive Study Results For PDS Biotechnology

Read more
7 Apr 2016 15:49

NetScientific losses widen as company remains optimistic

(ShareCast News) - NetScientific's losses widened in 2015, it reported on Thursday, though it was optimistic about the future having completed a radical restructure of its management and portfolio during the 12 months. The AIM-traded transatlantic technology healthcare group made a loss after tax of

Read more
7 Apr 2016 08:26

NetScientific Focused On Executing Under New Management, Loss Widens

Read more
5 Apr 2016 08:12

NetScientic Poaches New Finance Boss From Allergy Therapeutics

Read more
31 Mar 2016 15:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
29 Feb 2016 09:25

NetScientific's Wanda Partners With Dignity Health On Digital Platform

Read more
17 Feb 2016 16:17

Stephen Smith joins NetScientific board

(ShareCast News) - NetScientific added a big name in the British medical industry to its board on Wednesday, announcing the appointment of Professor Stephen Smith as a non-executive director. The AIM-traded biomedical and healthcare group said Smith had held senior roles in the NHS and academia, inc

Read more
17 Feb 2016 08:51

NetScientific Appoints NHS Veteran Stephen Smith To Board

Read more
9 Feb 2016 11:26

NetScientific Portfolio Company Inks US Government Research Deal

Read more
26 Jan 2016 09:08

NetScientific CFO To Leave, Finance Director To Step In For Interim

Read more
4 Jan 2016 07:43

NetScientific's WANDA Signs Deal With US Home Nursing Provider

Read more
3 Dec 2015 08:09

NetScientific Says ProAxis To Present Positive ProteaseTag Data

Read more
30 Nov 2015 09:34

NetScientific's ProAxsis To Present Data Supporting ProteaseTag Assays

Read more
78910111213141516

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.